ADAstrid DeVriese

Astrid DeVriese

*This is an algorithmically generated author record based on publicly available information.

Astrid DeVriese has a total of 21 co-authors. Here are the top co-authors by number of shared publications:

  • Edward M. Conway

    Centre for Blood Research, Life Sciences Institute, University of British Columbia, Vancouver, Canada

    2 shared publications
  • Amelia J. Eisch

    Department of Neuroscience, Mahoney Institute for Neurosciences, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Neuroscience Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Anesthesiology and Critical Care Medicine, The Children's Hospital of Philadelphia Research Institute, Philadelphia, Pennsylvania

    1 shared publication
  • Detlef Balschun

    Laboratory of Biological Psychology, Faculty of Psychology and Educational Sciences Katholieke Universiteit Leuven Leuven Belgium

    1 shared publication
  • Diane C. Lagace

    Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada

    1 shared publication
  • Flavia Antonucci

    Department of Medical Biotechnology and Translational Medicine (BIOMETRA), University of Milan, 20100 Milan, Italy

    1 shared publication
  • Harold Cremer

    Aix Marseille University, CNRS, IBDM, Campus de Luminy

    1 shared publication

Latest Publications

  • Open Access

    CD248 facilitates tumor growth via its cytoplasmic domain

    by Margarida Maia, Astrid DeVriese, Tom Janssens, Michaël Moons, Rik J Lories, Jan Tavernier, Edward M Conway

    Background: Stromal fibroblasts participate in the development of a permissive environment for tumor growth, yet molecular pathways to therapeutically target fibroblasts are poorly defined. CD248, also known as endosialin or tumor endothelial marker 1 (TEM1), is a transmembrane glycoprotein expressed on activated fibroblasts. We recently showed that the cytoplasmic domain of CD248 is important in facilitating an inflammatory response in a mouse model of arthritis. Others have reported thatCD248gene inactivation in mice results in dampened tumor growth. We hypothesized that the conserved cytoplasmic domain of CD248 is important in regulating tumor growth.Methods: Mice lacking the cytoplasmic domain of CD248 (CD248CyD/CyD) were generated and evaluated in tumor models, comparing the findings with wild-type mice (CD248WT/WT).Results: As compared to the response in CD248WT/WTmice, growth of T241 fibrosarcomas and Lewis lung carcinomas was significantly reduced in CD248CyD/CyDmice. Tumor size was similar to that seen with CD248-deficient mice. Conditioned media from CD248CyD/CyDfibroblasts were less effective at supporting T241 fibrosarcoma cell survival. In addition to our previous observation of reduced release of activated matrix metalloproteinase (MMP)-9, CD248CyD/CyDfibroblasts also had impaired PDGF-BB-induced migration and expressed higher transcripts of tumor suppressor factors, transgelin (SM22α), Hes and Hey1.Conclusions: The multiple pathways regulated by the cytoplasmic domain of CD248 highlight its potential as a therapeutic target to treat cancer.


  • Open Access

    Impaired neurogenesis, learning and memory and low seizure threshold associated with loss of neural precursor cell survivin

    by Vanessa Coremans, Tariq Ahmed, Detlef Balschun, Rudi D'Hooge, Astrid DeVriese, Jonathan Cremer, Flavia Antonucci, Michaël Moons, Veerle Baekelandt, Veerle Reumers, et al.

    Background: Survivin is a unique member of the inhibitor of apoptosis protein (IAP) family in that it exhibits antiapoptotic properties and also promotes the cell cycle and mediates mitosis as a chromosome passenger protein. Survivin is highly expressed in neural precursor cells in the brain, yet its function there has not been elucidated. Results: To examine the role of neural precursor cell survivin, we first showed that survivin is normally expressed in periventricular neurogenic regions in the embryo, becoming restricted postnatally to proliferating and migrating NPCs in the key neurogenic sites, the subventricular zone (SVZ) and the subgranular zone (SGZ). We then used a conditional gene inactivation strategy to delete the survivin gene prenatally in those neurogenic regions. Lack of embryonic NPC survivin results in viable, fertile mice (Survivin Camcre ) with reduced numbers of SVZ NPCs, absent rostral migratory stream, and olfactory bulb hypoplasia. The phenotype can be partially rescued, as intracerebroventricular gene delivery of survivin during embryonic development increases olfactory bulb neurogenesis, detected postnatally. Survivin Camcre brains have fewer cortical inhibitory interneurons, contributing to enhanced sensitivity to seizures, and profound deficits in memory and learning. Conclusions: The findings highlight the critical role that survivin plays during neural development, deficiencies of which dramatically impact on postnatal neural function.